| Log in

Licensing income can bring upsides to our target of $1B revenue by 2018: Kiran Mazumdar-Shaw of Biocon

07 May, 2014

Biocon Ltd is India’s largest biotechnology company founded by Kiran Mazumdar-Shaw in 1978. The company, which started with an initial investment of Rs 10,000, reported revenue o ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
GE Capital arm picks up stake in Biocon subsidiary for $23M

GE Capital arm picks up stake in Biocon subsidiary for $23M

Madhav A Chanchani 5 years ago
The private equity arm of GE Capital is acquiring stake in a subsidiary of...
Biocon plans IPO for IVFA-backed drug discovery services arm Syngene

Biocon plans IPO for IVFA-backed drug discovery services arm Syngene

Jasleen Kaur Batra 3 years ago
Biocon Ltd is looking to offload up to 15 per cent in its research arm Syngene...
Biocon subsidiary Syngene International looking to raise over $50M

Biocon subsidiary Syngene International looking to raise over $50M

Jasleen Kaur Batra 3 years ago
Syngene International, a subsidiary of Biocon Ltd, a generics major that also...
No Comments

Licensing income can bring upsides to our target of $1B revenue by 2018: Kiran Mazumdar-Shaw of Biocon

Powered by WordPress.com VIP